Amarin Corp Plc (AMRN)

[TSS-TheSlominShield]

Professor Mann’s argument seems to be based on two fundamental premises:
1) his impressive credentials enable him to read the minds of the justices
2) Hikma’s aggressive marketing of its “generic version of VASCEPA” is analogous to an internet service provider’s (Cox Communications) failure to police its platform for infringement of SONY’s copyrights.
Professor surely knows infinitely more about patent law than I do but I will wager that this particular blog does not age well.